Can brain scans unlock hidden effects of becker muscular dystrophy?

NCT ID NCT07740057

Not yet recruiting Knowledge-focused Sponsor: Institut de Myologie, France Source: ClinicalTrials.gov ↗

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This study looks at how the absence of a protein called Dp140 in people with Becker muscular dystrophy might affect the brain, thinking, and muscle function. Researchers will use brain and muscle imaging, along with cognitive and psychological tests, to explore these connections. The goal is to gather detailed information that could help future research and improve understanding of the disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: This research could improve understanding of how Becker muscular dystrophy affects the brain and thinking, potentially guiding future treatments and care.
What could go wrong: This is an observational study, so it won't test a treatment. Results may not apply to all patients, and the findings are exploratory.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BECKER MUSCULAR DYSTROPHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Becker muscular dystrophy Duchenne muscular dystrophy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BECKER MUSCULAR DYSTROPHY

Contacts and locations

Locations

Institute of Mythology

Paris, 75651, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.